INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1437856375-lnp-lipid-nanoparticle]( "Nanomedicine Modalities Find Path To Clinic Through Analytics")
Nanomedicine Modalities Find Path To Clinic Through AnalyticsLipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
![Eliminate Risk From Your Viral Vector Tech Transfers: Proven Strategies And Best Practices]( "Eliminate Risk From Your Viral Vector Tech Transfers")
Eliminate Risk From Your Viral Vector Tech TransfersExplore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.
-
Peptones And Vaccines: A Synergistic Approach To Enhanced Production And Efficiency
Enhance your vaccine manufacturing with peptones. Explore their benefits, analyze data-driven productivity gains, and learn integration strategies in this informative, on-demand session.
-
![GettyImages-1493586956-assay-bottles-laboratory-scientist]( "Fast And Scalable Fc Quantitation In Supernatants")
Fast And Scalable Fc Quantitation In SupernatantsIn biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose12/30/2024
Explore lactose monohydrate and CMC rheology, highlighting their flow, cohesion, and compressibility properties to optimize pharmaceutical formulations under varying stress and temperature conditions.
-
Combining Digital Platforms And QbD Principles7/9/2024
How can data and digitalization further improve pharmaceutical development and the continuous, quick, and efficient delivery of products?
-
Exosome Production From hMSC Using A Fixed-Bed Bioreactor11/3/2025
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
Overcoming Challenges In Ophthalmic Formulations8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
DRUG DEVELOPMENT SOLUTIONS
-
![Observe Cell viability With SpectraMax MiniMax 300 Imaging Cytometer]( "Observe Cell Viability With SpectraMax MiniMax 300 Imaging Cytometer")
Observe the viability of your cells with the field-upgradeable cellular imaging option for the SpectraMax i3/i3x Multi-mode Detection Platform.
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.
-
![Powder Rheology Feature]( "Powder Rheology Accessory")
The Powder Rheology Accessory expands the DHR’s capabilities to powders, enabling the characterization of behaviors during storage, dispensing, processing, and end-use.
-
![GettyImages-1218520471-development-research-lab-PPE]( "Early Development: Accelerating Molecules Through To Proof-Of-Concept")
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
![Scientist Using Tablet In Lab GettyImages-1354172577]( "PBPK Predictive Modeling Services")
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
